These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3323779)

  • 21. Methods of enhancing the frequency of antigen-specific hybridomas.
    Siraganian RP; Fox PC; Berenstein EH
    Methods Enzymol; 1983; 92():17-26. PubMed ID: 6855610
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemically defined medium for the growth of lymphocytes.
    Matthews KS; Pettit F; Boghossian J; Shive W
    Methods Enzymol; 1987; 150():134-46. PubMed ID: 3123877
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of 5-fluoro-2'-deoxyuridine (FdUrd) on 5-bromo-2'-deoxyuridine (BrdUrd) incorporation into DNA measured with a monoclonal BrdUrd antibody and by the BrdUrd/Hoechst quenching effect.
    Ellwart J; Dörmer P
    Cytometry; 1985 Nov; 6(6):513-20. PubMed ID: 2415309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal anti-Fc IgG receptor antibodies trigger B lymphocyte function.
    Lamers MC; Heckford SE; Dickler HB
    Nature; 1982 Jul; 298(5870):178-80. PubMed ID: 6211625
    [No Abstract]   [Full Text] [Related]  

  • 25. Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen.
    Lazarovits AI; Moscicki RA; Kurnick JT; Camerini D; Bhan AK; Baird LG; Erikson M; Colvin RB
    J Immunol; 1984 Oct; 133(4):1857-62. PubMed ID: 6088627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discrimination of cell nuclei in early S-phase, mid-to-late S-phase, and G(2)/M-phase by sequential administration of 5-bromo-2'-deoxyuridine and 5-chloro-2'-deoxyuridine.
    Yamada K; Semba R; Ding X; Ma N; Nagahama M
    J Histochem Cytochem; 2005 Nov; 53(11):1365-70. PubMed ID: 15956030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunocompetence status as related to growth progression of mouse MOPC-315 plasmacytoma.
    Rashid G; Ophir R; Pecht M; Ben-Efraim S
    In Vivo; 1989; 3(4):279-84. PubMed ID: 2535271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cell kinetics in human anagen hair and hair follicles studied with bromodeoxyuridine (BrdU) and anti-BrdU monoclonal antibody].
    Egawa K; Yoshimura K; Kageshita T; Ono T
    Nihon Hifuka Gakkai Zasshi; 1988 Jan; 98(1):61-4. PubMed ID: 3043063
    [No Abstract]   [Full Text] [Related]  

  • 29. Release of immunosuppressive factor(s) by MOPC-315 murine plasmacytoma cells: a possible mechanism of defence.
    Bomstein Y; Ophir R; Harshemes H; Ben-Efraim S
    Anticancer Res; 1993; 13(6A):2125-9. PubMed ID: 8297124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Separation of lymphocytes on antibody-coated plates.
    Mage MG
    Methods Enzymol; 1984; 108():118-24. PubMed ID: 6527647
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-bromodeoxyuridine monoclonal antibody: an alternative tool for the identification of replicated DNA at the electron microscope level.
    Thiry M; Dombrowicz D
    Biol Cell; 1988; 62(1):99-102. PubMed ID: 2966644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of tissue fixation on anti-bromodeoxyuridine immunohistochemistry.
    Schutte B; Reynders MM; Bosman FT; Blijham GH
    J Histochem Cytochem; 1987 Nov; 35(11):1343-5. PubMed ID: 3116075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies in the analysis of embryonic development.
    Bedian V
    Methods Mol Biol; 2000; 137():159-66. PubMed ID: 10948535
    [No Abstract]   [Full Text] [Related]  

  • 34. Significant non-S-phase DNA synthesis visualized by flow cytometry in activated and in malignant human lymphoid cells.
    Neckers LM; Funkhouser WK; Trepel JB; Cossman J; Gratzner HG
    Exp Cell Res; 1985 Feb; 156(2):429-38. PubMed ID: 3917926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A sensitive and class specific solid phase enzyme immunoassay for anti-DNA autoantibodies in supernatants of lymphocyte cultures and human hybridomas.
    Hiepe F; Kiessig ST; Jahn S; Volk HD; Grunow R; Apostoloff E; von Baehr R
    Biomed Biochim Acta; 1986; 45(7):K29-35. PubMed ID: 3539108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single-step technique for selecting and cloning hybridomas for monoclonal antibody production.
    Davis JM
    Methods Enzymol; 1986; 121():307-22. PubMed ID: 3487692
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunofluorescent staining method for use with monoclonal antibodies.
    Costanzo C; Raza A
    Cell Biochem Funct; 1984 Jul; 2(3):153-4. PubMed ID: 6383651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effector and enhancing lymphoid cells in plasmacytoma-bearing mice. I. Methodological studies on the Winn assay.
    Wang KC; Berczi I; Sehon AH
    Int J Cancer; 1980 Apr; 25(4):487-92. PubMed ID: 7372372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular expression of idiotopes defined by monoclonal antibodies.
    Bast BJ; Cooper MD; Kearney JF
    Eur J Immunol; 1984 Jul; 14(7):623-8. PubMed ID: 6204878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effector and enhancing lymphoid cells in plasmacytoma-bearing mice. II. Dynamic changes during tumor progression.
    Wang WC; Berczi I; Hoffmann EG; Sehon AH
    Int J Cancer; 1980 Apr; 25(4):493-501. PubMed ID: 6246008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.